FLT3LG and neoplasm: ,81 As pointed out in the latter, this may have been due to the advanced state of the cancers and insufficient TNF blockade, because we found that when non-tumor cells in the tumor microenvironment cannot produce TNF, treatment with agonistic anti-CD40 and Flt3L was very effective and actually eliminated established KPC cell tumors.